Oxford BioMedica PLC (OXB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oxford BioMedica PLC (OXB) has a cash flow conversion efficiency ratio of 0.072x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX2.35 Million ≈ $286.41 USD) by net assets (GBX32.73 Million ≈ $3.98K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OXB stock market capitalisation for the company's overall valuation and market capitalisation.
Oxford BioMedica PLC - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how Oxford BioMedica PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Oxford BioMedica PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oxford BioMedica PLC ranked by their cash flow conversion efficiency. Explore OXB cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Companhia Paranaense de Energia Pref ADR
NYSE:ELP
|
0.030x |
|
Nexalin Technology Inc.
NASDAQ:NXL
|
-0.593x |
|
Close Brothers Group plc
LSE:CBG
|
0.098x |
|
Renoworks Software Inc
V:RW
|
5.279x |
|
Ladangbaja Murni PT Tbk
JK:LABA
|
-0.054x |
|
Lomiko Metals Inc
V:LMR
|
-0.093x |
|
Jatcorp Ltd
AU:JAT
|
0.335x |
|
HydrogenPro AS
OL:HYPRO
|
-0.052x |
Annual Cash Flow Conversion Efficiency for Oxford BioMedica PLC (1996–2024)
The table below shows the annual cash flow conversion efficiency of Oxford BioMedica PLC from 1996 to 2024. View current stock price of Oxford BioMedica PLC for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX60.49 Million ≈ $7.36K |
GBX-50.63 Million ≈ $-6.16K |
-0.837x | -128.45% |
| 2023-12-31 | GBX77.83 Million ≈ $9.47K |
GBX-28.52 Million ≈ $-3.47K |
-0.366x | -585.98% |
| 2022-12-31 | GBX236.19 Million ≈ $28.74K |
GBX-12.62 Million ≈ $-1.53K |
-0.053x | -139.31% |
| 2021-12-31 | GBX187.34 Million ≈ $22.79K |
GBX25.45 Million ≈ $3.10K |
0.136x | +391.64% |
| 2020-12-31 | GBX112.75 Million ≈ $13.72K |
GBX3.12 Million ≈ $379.13 |
0.028x | +159.58% |
| 2019-12-31 | GBX75.63 Million ≈ $9.20K |
GBX-3.51 Million ≈ $-426.82 |
-0.046x | -112.52% |
| 2018-12-31 | GBX34.74 Million ≈ $4.23K |
GBX12.87 Million ≈ $1.57K |
0.370x | -23.58% |
| 2017-12-31 | GBX6.15 Million ≈ $747.79 |
GBX2.98 Million ≈ $362.46 |
0.485x | +219.75% |
| 2016-12-31 | GBX12.62 Million ≈ $1.53K |
GBX-5.11 Million ≈ $-621.25 |
-0.405x | +66.39% |
| 2015-12-31 | GBX10.89 Million ≈ $1.33K |
GBX-13.12 Million ≈ $-1.60K |
-1.204x | -359.92% |
| 2014-12-31 | GBX23.04 Million ≈ $2.80K |
GBX-6.03 Million ≈ $-733.92 |
-0.262x | +78.86% |
| 2013-12-31 | GBX8.90 Million ≈ $1.08K |
GBX-11.02 Million ≈ $-1.34K |
-1.238x | -142.36% |
| 2012-12-31 | GBX19.64 Million ≈ $2.39K |
GBX-10.04 Million ≈ $-1.22K |
-0.511x | +30.06% |
| 2011-12-31 | GBX17.77 Million ≈ $2.16K |
GBX-12.98 Million ≈ $-1.58K |
-0.731x | +33.91% |
| 2010-12-31 | GBX11.61 Million ≈ $1.41K |
GBX-12.83 Million ≈ $-1.56K |
-1.105x | -1102.01% |
| 2009-12-31 | GBX20.98 Million ≈ $2.55K |
GBX2.31 Million ≈ $281.55 |
0.110x | +114.16% |
| 2008-12-31 | GBX23.27 Million ≈ $2.83K |
GBX-18.13 Million ≈ $-2.21K |
-0.779x | -626.04% |
| 2007-12-31 | GBX31.93 Million ≈ $3.89K |
GBX4.73 Million ≈ $575.50 |
0.148x | +126.02% |
| 2006-12-31 | GBX30.09 Million ≈ $3.66K |
GBX-17.13 Million ≈ $-2.08K |
-0.569x | -217.98% |
| 2005-12-31 | GBX46.60 Million ≈ $5.67K |
GBX-8.34 Million ≈ $-1.01K |
-0.179x | +54.45% |
| 2004-12-31 | GBX26.38 Million ≈ $3.21K |
GBX-10.37 Million ≈ $-1.26K |
-0.393x | -44.40% |
| 2003-12-31 | GBX35.21 Million ≈ $4.28K |
GBX-9.58 Million ≈ $-1.17K |
-0.272x | +32.51% |
| 2002-12-31 | GBX25.53 Million ≈ $3.11K |
GBX-10.30 Million ≈ $-1.25K |
-0.403x | -73.30% |
| 2001-12-31 | GBX37.51 Million ≈ $4.56K |
GBX-8.73 Million ≈ $-1.06K |
-0.233x | +38.36% |
| 2000-12-31 | GBX12.98 Million ≈ $1.58K |
GBX-4.90 Million ≈ $-596.07 |
-0.378x | +59.94% |
| 1999-12-31 | GBX3.80 Million ≈ $462.47 |
GBX-3.58 Million ≈ $-435.83 |
-0.942x | -33.06% |
| 1998-12-31 | GBX4.76 Million ≈ $579.28 |
GBX-3.37 Million ≈ $-410.27 |
-0.708x | -3219.94% |
| 1996-09-30 | GBX1.12 Million ≈ $136.88 |
GBX-24.00K ≈ $-2.92 |
-0.021x | -- |
About Oxford BioMedica PLC
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The… Read more